| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | CACNA1A SLC6A9 CACNA1E SLC8A2 SLC8A1 PIEZO2 NIPAL3 SLC1A2 SLC1A3 SLC1A6 SLC5A6 TPCN1 GABRA6 | 6.65e-12 | 793 | 27 | 13 | GO:0015075 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | CACNA1A SLC6A9 CACNA1E SLC8A2 SLC8A1 NIPAL3 SLC1A2 SLC1A3 SLC1A6 SLC5A6 TPCN1 | 9.05e-12 | 465 | 27 | 11 | GO:0046873 |
| GeneOntologyMolecularFunction | transporter activity | CACNA1A SLC6A9 CACNA1E SLC8A2 SLC8A1 ATP11A PIEZO2 FLVCR2 NIPAL3 SLC1A2 SLC1A3 SLC1A6 SLC5A6 TPCN1 GABRA6 | 1.08e-11 | 1289 | 27 | 15 | GO:0005215 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | CACNA1A SLC6A9 CACNA1E SLC8A2 SLC8A1 PIEZO2 NIPAL3 SLC1A2 SLC1A3 SLC1A6 SLC5A6 TPCN1 | 1.82e-11 | 664 | 27 | 12 | GO:0008324 |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 4.74e-11 | 171 | 27 | 8 | GO:0015081 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | CACNA1A SLC6A9 CACNA1E SLC8A2 SLC8A1 PIEZO2 FLVCR2 NIPAL3 SLC1A2 SLC1A3 SLC1A6 SLC5A6 TPCN1 GABRA6 | 5.70e-11 | 1180 | 27 | 14 | GO:0022857 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | CACNA1A SLC6A9 CACNA1E SLC8A2 SLC8A1 NIPAL3 SLC1A2 SLC1A3 SLC1A6 SLC5A6 TPCN1 GABRA6 | 8.45e-11 | 758 | 27 | 12 | GO:0015318 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | CACNA1A SLC6A9 CACNA1E SLC8A2 SLC8A1 NIPAL3 SLC1A2 SLC1A3 SLC1A6 SLC5A6 TPCN1 | 2.21e-10 | 627 | 27 | 11 | GO:0022890 |
| GeneOntologyMolecularFunction | organic acid:sodium symporter activity | 9.64e-10 | 35 | 27 | 5 | GO:0005343 | |
| GeneOntologyMolecularFunction | olfactory receptor activity | 3.11e-09 | 431 | 27 | 9 | GO:0004984 | |
| GeneOntologyMolecularFunction | high-affinity L-glutamate transmembrane transporter activity | 2.20e-08 | 5 | 27 | 3 | GO:0005314 | |
| GeneOntologyMolecularFunction | glutamate:sodium symporter activity | 2.20e-08 | 5 | 27 | 3 | GO:0015501 | |
| GeneOntologyMolecularFunction | amino acid:sodium symporter activity | 2.31e-08 | 23 | 27 | 4 | GO:0005283 | |
| GeneOntologyMolecularFunction | amino acid:monoatomic cation symporter activity | 6.15e-08 | 29 | 27 | 4 | GO:0005416 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 7.29e-08 | 81 | 27 | 5 | GO:0015370 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 1.01e-07 | 296 | 27 | 7 | GO:0015291 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 1.13e-07 | 301 | 27 | 7 | GO:0022853 | |
| GeneOntologyMolecularFunction | neutral L-amino acid transmembrane transporter activity | 2.59e-07 | 41 | 27 | 4 | GO:0015175 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 5.02e-07 | 119 | 27 | 5 | GO:0015294 | |
| GeneOntologyMolecularFunction | L-glutamate transmembrane transporter activity | 9.92e-07 | 15 | 27 | 3 | GO:0005313 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | 1.43e-06 | 884 | 27 | 9 | GO:0004930 | |
| GeneOntologyMolecularFunction | symporter activity | 1.58e-06 | 150 | 27 | 5 | GO:0015293 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.63e-06 | 151 | 27 | 5 | GO:0015085 | |
| GeneOntologyMolecularFunction | L-amino acid transmembrane transporter activity | 2.42e-06 | 71 | 27 | 4 | GO:0015179 | |
| GeneOntologyMolecularFunction | acidic amino acid transmembrane transporter activity | 2.48e-06 | 20 | 27 | 3 | GO:0015172 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | 2.49e-06 | 477 | 27 | 7 | GO:0022804 | |
| GeneOntologyMolecularFunction | calcium:monoatomic cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration | 5.28e-06 | 3 | 27 | 2 | GO:1905060 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | OR2W1 OR2D2 OR13H1 OR11L1 OR13C9 OR11H7 OR11H4 OR13C2 OR8K5 GABRA6 | 5.73e-06 | 1353 | 27 | 10 | GO:0004888 |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 7.65e-06 | 207 | 27 | 5 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 7.83e-06 | 208 | 27 | 5 | GO:0005342 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 1.15e-05 | 105 | 27 | 4 | GO:0015171 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 4.07e-05 | 293 | 27 | 5 | GO:0008514 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 4.82e-05 | 151 | 27 | 4 | GO:0008509 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of cytosolic calcium levels | 6.30e-05 | 9 | 27 | 2 | GO:0099511 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels | 6.30e-05 | 9 | 27 | 2 | GO:0099626 | |
| GeneOntologyMolecularFunction | gated channel activity | 7.58e-05 | 334 | 27 | 5 | GO:0022836 | |
| GeneOntologyMolecularFunction | calcium:sodium antiporter activity | 7.87e-05 | 10 | 27 | 2 | GO:0005432 | |
| GeneOntologyMolecularFunction | calcium:monoatomic cation antiporter activity | 1.36e-04 | 13 | 27 | 2 | GO:0015368 | |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 1.59e-04 | 14 | 27 | 2 | GO:0008331 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 3.34e-04 | 459 | 27 | 5 | GO:0005216 | |
| GeneOntologyMolecularFunction | channel activity | 6.16e-04 | 525 | 27 | 5 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 6.22e-04 | 526 | 27 | 5 | GO:0022803 | |
| GeneOntologyMolecularFunction | calcium channel activity | 6.88e-04 | 129 | 27 | 3 | GO:0005262 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 1.10e-03 | 343 | 27 | 4 | GO:0005261 | |
| GeneOntologyMolecularFunction | metal cation:monoatomic cation antiporter activity | 1.54e-03 | 43 | 27 | 2 | GO:0140828 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 1.76e-03 | 46 | 27 | 2 | GO:0005245 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 1.91e-03 | 184 | 27 | 3 | GO:0022832 | |
| GeneOntologyMolecularFunction | sulfur compound transmembrane transporter activity | 3.07e-03 | 61 | 27 | 2 | GO:1901682 | |
| GeneOntologyMolecularFunction | calmodulin binding | 3.60e-03 | 230 | 27 | 3 | GO:0005516 | |
| GeneOntologyMolecularFunction | organic cation transmembrane transporter activity | 5.60e-03 | 83 | 27 | 2 | GO:0015101 | |
| GeneOntologyMolecularFunction | syntaxin binding | 6.14e-03 | 87 | 27 | 2 | GO:0019905 | |
| GeneOntologyMolecularFunction | odorant binding | 1.27e-02 | 127 | 27 | 2 | GO:0005549 | |
| GeneOntologyMolecularFunction | SNARE binding | 1.45e-02 | 136 | 27 | 2 | GO:0000149 | |
| GeneOntologyMolecularFunction | antiporter activity | 1.49e-02 | 138 | 27 | 2 | GO:0015297 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 1.78e-02 | 152 | 27 | 2 | GO:0022843 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 2.22e-02 | 171 | 27 | 2 | GO:0015103 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 2.50e-02 | 182 | 27 | 2 | GO:0005244 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 2.78e-02 | 193 | 27 | 2 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 2.89e-02 | 197 | 27 | 2 | GO:0022834 | |
| GeneOntologyBiologicalProcess | import across plasma membrane | CACNA1A SLC6A9 CACNA1E SLC8A2 SLC8A1 SLC1A2 SLC1A3 SLC1A6 SLC5A6 | 8.97e-12 | 230 | 27 | 9 | GO:0098739 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | CACNA1A SLC6A9 CACNA1E SLC8A2 SLC8A1 PIEZO2 FLVCR2 NIPAL3 SLC1A2 SLC1A3 SLC1A6 SLC5A6 TPCN1 GABRA6 | 2.80e-10 | 1374 | 27 | 14 | GO:0006811 |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR2W1 OR2D2 OR13H1 OR11L1 PIEZO2 OR13C9 OR11H7 OR11H4 OR13C2 OR8K5 | 1.62e-09 | 582 | 27 | 10 | GO:0050906 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | 2.40e-09 | 432 | 27 | 9 | GO:0050911 | |
| GeneOntologyBiologicalProcess | sensory perception | OR2W1 CACNA1E OR2D2 OR13H1 OR11L1 PIEZO2 OR13C9 SLC1A3 OR11H7 OR11H4 OR13C2 OR8K5 | 3.08e-09 | 1072 | 27 | 12 | GO:0007600 |
| GeneOntologyBiologicalProcess | sensory perception of smell | 4.55e-09 | 465 | 27 | 9 | GO:0007608 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | CACNA1A SLC6A9 CACNA1E SLC8A2 SLC8A1 PIEZO2 NIPAL3 SLC1A2 SLC1A3 SLC5A6 TPCN1 GABRA6 | 4.79e-09 | 1115 | 27 | 12 | GO:0034220 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | 6.57e-09 | 485 | 27 | 9 | GO:0050907 | |
| GeneOntologyBiologicalProcess | detection of stimulus | OR2W1 OR2D2 OR13H1 OR11L1 PIEZO2 OR13C9 OR11H7 OR11H4 OR13C2 OR8K5 | 1.28e-08 | 722 | 27 | 10 | GO:0051606 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | 1.28e-08 | 524 | 27 | 9 | GO:0009593 | |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | 1.86e-08 | 547 | 27 | 9 | GO:0007606 | |
| GeneOntologyBiologicalProcess | L-aspartate import across plasma membrane | 3.99e-08 | 6 | 27 | 3 | GO:0140009 | |
| GeneOntologyBiologicalProcess | transport across blood-brain barrier | 8.92e-08 | 87 | 27 | 5 | GO:0150104 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | CACNA1A SLC6A9 CACNA1E SLC8A2 SLC8A1 PIEZO2 FLVCR2 NIPAL3 SLC1A3 SLC5A6 TPCN1 | 9.36e-08 | 1157 | 27 | 11 | GO:0006812 |
| GeneOntologyBiologicalProcess | vascular transport | 9.45e-08 | 88 | 27 | 5 | GO:0010232 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | CACNA1A SLC6A9 CACNA1E SLC8A2 SLC8A1 PIEZO2 NIPAL3 SLC1A3 SLC5A6 TPCN1 | 1.56e-07 | 942 | 27 | 10 | GO:0098655 |
| GeneOntologyBiologicalProcess | metal ion transport | CACNA1A SLC6A9 CACNA1E SLC8A2 SLC8A1 FLVCR2 NIPAL3 SLC1A3 SLC5A6 TPCN1 | 2.72e-07 | 1000 | 27 | 10 | GO:0030001 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | CACNA1A SLC6A9 CACNA1E SLC8A2 SLC8A1 NIPAL3 SLC1A3 SLC5A6 TPCN1 GABRA6 | 3.18e-07 | 1017 | 27 | 10 | GO:0098660 |
| GeneOntologyBiologicalProcess | L-aspartate transmembrane transport | 3.28e-07 | 11 | 27 | 3 | GO:0070778 | |
| GeneOntologyBiologicalProcess | calcium ion import across plasma membrane | 4.36e-07 | 48 | 27 | 4 | GO:0098703 | |
| GeneOntologyBiologicalProcess | calcium ion import into cytosol | 4.36e-07 | 48 | 27 | 4 | GO:1902656 | |
| GeneOntologyBiologicalProcess | import into cell | CACNA1A SLC6A9 CACNA1E SLC8A2 SLC8A1 SLC1A2 SLC1A3 SLC1A6 SLC5A6 TPCN1 | 5.26e-07 | 1074 | 27 | 10 | GO:0098657 |
| GeneOntologyBiologicalProcess | neurotransmitter uptake | 6.04e-07 | 52 | 27 | 4 | GO:0001504 | |
| GeneOntologyBiologicalProcess | neurotransmitter transport | 8.78e-07 | 259 | 27 | 6 | GO:0006836 | |
| GeneOntologyBiologicalProcess | amino acid import across plasma membrane | 9.41e-07 | 58 | 27 | 4 | GO:0089718 | |
| GeneOntologyBiologicalProcess | inorganic cation import across plasma membrane | 1.03e-06 | 142 | 27 | 5 | GO:0098659 | |
| GeneOntologyBiologicalProcess | inorganic ion import across plasma membrane | 1.03e-06 | 142 | 27 | 5 | GO:0099587 | |
| GeneOntologyBiologicalProcess | neutral amino acid transport | 1.08e-06 | 60 | 27 | 4 | GO:0015804 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | CACNA1A SLC6A9 CACNA1E SLC8A2 SLC8A1 NIPAL3 SLC1A3 SLC5A6 TPCN1 | 1.55e-06 | 922 | 27 | 9 | GO:0098662 |
| GeneOntologyBiologicalProcess | L-glutamate import across plasma membrane | 1.91e-06 | 19 | 27 | 3 | GO:0098712 | |
| GeneOntologyBiologicalProcess | carboxylic acid transmembrane transport | 2.03e-06 | 163 | 27 | 5 | GO:1905039 | |
| GeneOntologyBiologicalProcess | organic acid transmembrane transport | 2.29e-06 | 167 | 27 | 5 | GO:1903825 | |
| GeneOntologyBiologicalProcess | circulatory system process | 2.98e-06 | 733 | 27 | 8 | GO:0003013 | |
| GeneOntologyBiologicalProcess | aspartate transmembrane transport | 3.03e-06 | 22 | 27 | 3 | GO:0015810 | |
| GeneOntologyBiologicalProcess | vascular process in circulatory system | 4.54e-06 | 344 | 27 | 6 | GO:0003018 | |
| GeneOntologyBiologicalProcess | L-alpha-amino acid transmembrane transport | 4.81e-06 | 87 | 27 | 4 | GO:1902475 | |
| GeneOntologyBiologicalProcess | amino acid transport | 4.89e-06 | 195 | 27 | 5 | GO:0006865 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 6.70e-06 | 208 | 27 | 5 | GO:0035725 | |
| GeneOntologyBiologicalProcess | C4-dicarboxylate transport | 7.15e-06 | 29 | 27 | 3 | GO:0015740 | |
| GeneOntologyBiologicalProcess | calcium ion import | 7.73e-06 | 98 | 27 | 4 | GO:0070509 | |
| GeneOntologyBiologicalProcess | L-amino acid transport | 1.14e-05 | 108 | 27 | 4 | GO:0015807 | |
| GeneOntologyBiologicalProcess | carboxylic acid transport | 1.24e-05 | 410 | 27 | 6 | GO:0046942 | |
| GeneOntologyBiologicalProcess | organic acid transport | 1.27e-05 | 412 | 27 | 6 | GO:0015849 | |
| GeneOntologyBiologicalProcess | L-glutamate transmembrane transport | 1.27e-05 | 35 | 27 | 3 | GO:0015813 | |
| GeneOntologyBiologicalProcess | amino acid transmembrane transport | 1.72e-05 | 120 | 27 | 4 | GO:0003333 | |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | 1.72e-05 | 931 | 27 | 8 | GO:0098916 | |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | 1.72e-05 | 931 | 27 | 8 | GO:0007268 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | 1.83e-05 | 939 | 27 | 8 | GO:0099537 | |
| GeneOntologyBiologicalProcess | cellular response to alkaloid | 1.91e-05 | 40 | 27 | 3 | GO:0071312 | |
| GeneOntologyBiologicalProcess | synaptic signaling | 2.42e-05 | 976 | 27 | 8 | GO:0099536 | |
| GeneOntologyBiologicalProcess | D-aspartate import across plasma membrane | 2.47e-05 | 6 | 27 | 2 | GO:0070779 | |
| GeneOntologyBiologicalProcess | D-aspartate transmembrane transport | 2.47e-05 | 6 | 27 | 2 | GO:0070777 | |
| GeneOntologyBiologicalProcess | sodium ion transport | 2.58e-05 | 275 | 27 | 5 | GO:0006814 | |
| GeneOntologyBiologicalProcess | L-glutamate import | 2.92e-05 | 46 | 27 | 3 | GO:0051938 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | 4.43e-05 | 1395 | 27 | 9 | GO:0007186 | |
| GeneOntologyBiologicalProcess | organic anion transport | 4.46e-05 | 515 | 27 | 6 | GO:0015711 | |
| GeneOntologyBiologicalProcess | monoatomic anion transmembrane transport | 4.47e-05 | 153 | 27 | 4 | GO:0098656 | |
| GeneOntologyBiologicalProcess | D-amino acid transport | 4.60e-05 | 8 | 27 | 2 | GO:0042940 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | 7.03e-05 | 559 | 27 | 6 | GO:0042391 | |
| GeneOntologyBiologicalProcess | cellular response to cocaine | 7.38e-05 | 10 | 27 | 2 | GO:0071314 | |
| GeneOntologyBiologicalProcess | monoatomic anion transport | 8.97e-05 | 183 | 27 | 4 | GO:0006820 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | 1.38e-04 | 392 | 27 | 5 | GO:0070588 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane import into cytosol | 1.73e-04 | 217 | 27 | 4 | GO:0097553 | |
| GeneOntologyBiologicalProcess | acidic amino acid transport | 1.78e-04 | 84 | 27 | 3 | GO:0015800 | |
| GeneOntologyBiologicalProcess | regulation of heart contraction | 2.92e-04 | 249 | 27 | 4 | GO:0008016 | |
| GeneOntologyBiologicalProcess | calcium ion transport | 4.62e-04 | 509 | 27 | 5 | GO:0006816 | |
| GeneOntologyBiologicalProcess | dicarboxylic acid transport | 5.07e-04 | 120 | 27 | 3 | GO:0006835 | |
| GeneOntologyBiologicalProcess | sodium ion import across plasma membrane | 5.68e-04 | 27 | 27 | 2 | GO:0098719 | |
| GeneOntologyBiologicalProcess | response to alkaloid | 5.71e-04 | 125 | 27 | 3 | GO:0043279 | |
| GeneOntologyBiologicalProcess | heart contraction | 5.77e-04 | 298 | 27 | 4 | GO:0060047 | |
| GeneOntologyBiologicalProcess | regulation of heart rate | 6.26e-04 | 129 | 27 | 3 | GO:0002027 | |
| GeneOntologyBiologicalProcess | regulation of cardiac conduction | 6.56e-04 | 29 | 27 | 2 | GO:1903779 | |
| GeneOntologyBiologicalProcess | heart process | 6.60e-04 | 309 | 27 | 4 | GO:0003015 | |
| GeneOntologyBiologicalProcess | inorganic anion transmembrane transport | 7.00e-04 | 134 | 27 | 3 | GO:0098661 | |
| GeneOntologyBiologicalProcess | intracellular sodium ion homeostasis | 7.02e-04 | 30 | 27 | 2 | GO:0006883 | |
| GeneOntologyBiologicalProcess | behavioral response to pain | 7.99e-04 | 32 | 27 | 2 | GO:0048266 | |
| GeneOntologyBiologicalProcess | regulation of blood circulation | 8.07e-04 | 326 | 27 | 4 | GO:1903522 | |
| GeneOntologyBiologicalProcess | behavior | 8.67e-04 | 891 | 27 | 6 | GO:0007610 | |
| GeneOntologyBiologicalProcess | organic cation transport | 8.80e-04 | 145 | 27 | 3 | GO:0015695 | |
| GeneOntologyBiologicalProcess | gamma-aminobutyric acid signaling pathway | 9.56e-04 | 35 | 27 | 2 | GO:0007214 | |
| GeneOntologyBiologicalProcess | transepithelial transport | 1.13e-03 | 38 | 27 | 2 | GO:0070633 | |
| GeneOntologyBiologicalProcess | calcium ion transport into cytosol | 1.38e-03 | 42 | 27 | 2 | GO:0060402 | |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | 1.52e-03 | 663 | 27 | 5 | GO:0050804 | |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | 1.53e-03 | 664 | 27 | 5 | GO:0099177 | |
| GeneOntologyBiologicalProcess | inorganic anion transport | 1.64e-03 | 180 | 27 | 3 | GO:0015698 | |
| GeneOntologyBiologicalProcess | response to pain | 2.02e-03 | 51 | 27 | 2 | GO:0048265 | |
| GeneOntologyBiologicalProcess | sodium ion homeostasis | 2.02e-03 | 51 | 27 | 2 | GO:0055078 | |
| GeneOntologyBiologicalProcess | signal release from synapse | 2.06e-03 | 195 | 27 | 3 | GO:0099643 | |
| GeneOntologyBiologicalProcess | neurotransmitter secretion | 2.06e-03 | 195 | 27 | 3 | GO:0007269 | |
| GeneOntologyBiologicalProcess | cellular response to nitrogen compound | 2.63e-03 | 752 | 27 | 5 | GO:1901699 | |
| GeneOntologyBiologicalProcess | positive regulation of cytosolic calcium ion concentration | 3.05e-03 | 224 | 27 | 3 | GO:0007204 | |
| GeneOntologyBiologicalProcess | sulfur compound transport | 3.26e-03 | 65 | 27 | 2 | GO:0072348 | |
| GeneOntologyCellularComponent | synaptic membrane | 4.85e-07 | 583 | 27 | 8 | GO:0097060 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 6.18e-07 | 405 | 27 | 7 | GO:0045211 | |
| GeneOntologyCellularComponent | presynaptic membrane | 1.20e-06 | 277 | 27 | 6 | GO:0042734 | |
| GeneOntologyCellularComponent | postsynapse | CACNA1A SLC6A9 CACNA1E SLC8A2 SLC8A1 SLC1A2 SLC1A3 SLC1A6 GABRA6 | 3.15e-06 | 1018 | 27 | 9 | GO:0098794 |
| GeneOntologyCellularComponent | presynapse | 1.09e-05 | 886 | 27 | 8 | GO:0098793 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | 4.99e-05 | 320 | 27 | 5 | GO:0016323 | |
| GeneOntologyCellularComponent | basal plasma membrane | 8.04e-05 | 354 | 27 | 5 | GO:0009925 | |
| GeneOntologyCellularComponent | basal part of cell | 1.10e-04 | 378 | 27 | 5 | GO:0045178 | |
| GeneOntologyCellularComponent | cell body | 1.36e-04 | 929 | 27 | 7 | GO:0044297 | |
| GeneOntologyCellularComponent | dendritic spine | 2.49e-04 | 242 | 27 | 4 | GO:0043197 | |
| GeneOntologyCellularComponent | neuron spine | 2.70e-04 | 247 | 27 | 4 | GO:0044309 | |
| GeneOntologyCellularComponent | neuronal cell body | 5.75e-04 | 835 | 27 | 6 | GO:0043025 | |
| GeneOntologyCellularComponent | transporter complex | 6.19e-04 | 550 | 27 | 5 | GO:1990351 | |
| GeneOntologyCellularComponent | dendrite | 6.63e-04 | 858 | 27 | 6 | GO:0030425 | |
| GeneOntologyCellularComponent | dendritic tree | 6.71e-04 | 860 | 27 | 6 | GO:0097447 | |
| GeneOntologyCellularComponent | somatodendritic compartment | 7.45e-04 | 1228 | 27 | 7 | GO:0036477 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 1.33e-03 | 378 | 27 | 4 | GO:0034702 | |
| GeneOntologyCellularComponent | parallel fiber to Purkinje cell synapse | 1.40e-03 | 43 | 27 | 2 | GO:0098688 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 1.61e-03 | 46 | 27 | 2 | GO:0005891 | |
| GeneOntologyCellularComponent | membrane protein complex | 2.38e-03 | 1498 | 27 | 7 | GO:0098796 | |
| GeneOntologyCellularComponent | perikaryon | 2.90e-03 | 223 | 27 | 3 | GO:0043204 | |
| GeneOntologyCellularComponent | neuron projection terminus | 3.28e-03 | 233 | 27 | 3 | GO:0044306 | |
| GeneOntologyCellularComponent | hippocampal mossy fiber to CA3 synapse | 3.37e-03 | 67 | 27 | 2 | GO:0098686 | |
| GeneOntologyCellularComponent | postsynaptic specialization | 3.75e-03 | 503 | 27 | 4 | GO:0099572 | |
| GeneOntologyCellularComponent | calcium channel complex | 3.99e-03 | 73 | 27 | 2 | GO:0034704 | |
| GeneOntologyCellularComponent | dendritic shaft | 4.10e-03 | 74 | 27 | 2 | GO:0043198 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 4.30e-03 | 523 | 27 | 4 | GO:0098984 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | 4.30e-03 | 523 | 27 | 4 | GO:1902495 | |
| GeneOntologyCellularComponent | neuron projection membrane | 5.01e-03 | 82 | 27 | 2 | GO:0032589 | |
| GeneOntologyCellularComponent | excitatory synapse | 8.38e-03 | 107 | 27 | 2 | GO:0060076 | |
| HumanPheno | Episodic hemiplegia | 2.08e-05 | 4 | 10 | 2 | HP:0012194 | |
| HumanPheno | Abnormal corpus callosum morphology | 4.04e-05 | 937 | 10 | 8 | HP:0001273 | |
| HumanPheno | Skewfoot | 5.18e-05 | 6 | 10 | 2 | HP:0032649 | |
| HumanPheno | Ocular flutter | 5.18e-05 | 6 | 10 | 2 | HP:0031931 | |
| HumanPheno | Abnormal cerebral white matter morphology | 1.50e-04 | 1114 | 10 | 8 | HP:0002500 | |
| HumanPheno | Areflexia | 1.68e-04 | 314 | 10 | 5 | HP:0001284 | |
| HumanPheno | Joint contracture | 2.51e-04 | 843 | 10 | 7 | HP:0034392 | |
| HumanPheno | Abnormal cerebral subcortex morphology | 2.75e-04 | 1207 | 10 | 8 | HP:0010993 | |
| HumanPheno | Abnormal brainstem morphology | 2.89e-04 | 352 | 10 | 5 | HP:0002363 | |
| HumanPheno | Thin corpus callosum | 3.04e-04 | 868 | 10 | 7 | HP:0033725 | |
| HumanPheno | Abnormal tendon morphology | 3.20e-04 | 875 | 10 | 7 | HP:0100261 | |
| HumanPheno | Paroxysmal dyskinesia | 4.10e-04 | 16 | 10 | 2 | HP:0007166 | |
| HumanPheno | Mydriasis | 4.10e-04 | 16 | 10 | 2 | HP:0011499 | |
| HumanPheno | Reduced tendon reflexes | 4.21e-04 | 617 | 10 | 6 | HP:0001315 | |
| HumanPheno | Abnormal nervous system electrophysiology | 4.55e-04 | 924 | 10 | 7 | HP:0001311 | |
| HumanPheno | Status epilepticus | 4.59e-04 | 207 | 10 | 4 | HP:0002133 | |
| HumanPheno | Atrophy/Degeneration affecting the central nervous system | 6.22e-04 | 1347 | 10 | 8 | HP:0007367 | |
| HumanPheno | Saccadic oscillation | 7.14e-04 | 21 | 10 | 2 | HP:0032104 | |
| HumanPheno | Poor head control | 7.44e-04 | 235 | 10 | 4 | HP:0002421 | |
| HumanPheno | Focal tonic seizure | 8.59e-04 | 23 | 10 | 2 | HP:0011167 | |
| MousePheno | prolonged excitatory postsynaptic current decay time | 3.43e-05 | 8 | 16 | 2 | MP:0011273 | |
| Domain | Olfact_rcpt | 4.01e-08 | 393 | 26 | 8 | IPR000725 | |
| Domain | NA_DICARBOXYL_SYMP_1 | 8.35e-08 | 7 | 26 | 3 | PS00713 | |
| Domain | NA_DICARBOXYL_SYMP_2 | 8.35e-08 | 7 | 26 | 3 | PS00714 | |
| Domain | Na-dicarboxylate_symporter | 8.35e-08 | 7 | 26 | 3 | IPR001991 | |
| Domain | Na-dicarboxylate_symporter_CS | 8.35e-08 | 7 | 26 | 3 | IPR018107 | |
| Domain | SDF | 8.35e-08 | 7 | 26 | 3 | PF00375 | |
| Domain | - | 8.35e-08 | 7 | 26 | 3 | 1.10.3860.10 | |
| Domain | GPCR_Rhodpsn_7TM | 2.32e-06 | 670 | 26 | 8 | IPR017452 | |
| Domain | 7tm_1 | 2.50e-06 | 677 | 26 | 8 | PF00001 | |
| Domain | G_PROTEIN_RECEP_F1_1 | 2.73e-06 | 685 | 26 | 8 | PS00237 | |
| Domain | G_PROTEIN_RECEP_F1_2 | 2.91e-06 | 691 | 26 | 8 | PS50262 | |
| Domain | GPCR_Rhodpsn | 2.95e-06 | 692 | 26 | 8 | IPR000276 | |
| Domain | Na_Ca_ex_C | 5.59e-06 | 3 | 26 | 2 | PF16494 | |
| Domain | Na_Ca_Ex_C-exten | 5.59e-06 | 3 | 26 | 2 | IPR032452 | |
| Domain | Na_Ca_Ex | 5.59e-06 | 3 | 26 | 2 | IPR004836 | |
| Domain | Ca_chan_IQ | 3.90e-05 | 7 | 26 | 2 | PF08763 | |
| Domain | GPHH | 3.90e-05 | 7 | 26 | 2 | PF16905 | |
| Domain | GPHH_dom | 3.90e-05 | 7 | 26 | 2 | IPR031649 | |
| Domain | VDCC_a1su_IQ | 3.90e-05 | 7 | 26 | 2 | IPR014873 | |
| Domain | Ca_chan_IQ | 3.90e-05 | 7 | 26 | 2 | SM01062 | |
| Domain | Calx_beta | 5.19e-05 | 8 | 26 | 2 | SM00237 | |
| Domain | Channel_four-helix_dom | 6.67e-05 | 57 | 26 | 3 | IPR027359 | |
| Domain | - | 6.67e-05 | 57 | 26 | 3 | 1.20.120.350 | |
| Domain | Calx_beta | 6.67e-05 | 9 | 26 | 2 | IPR003644 | |
| Domain | Na_Ca_ex | 6.67e-05 | 9 | 26 | 2 | PF01699 | |
| Domain | Calx-beta | 6.67e-05 | 9 | 26 | 2 | PF03160 | |
| Domain | NaCa_Exmemb | 6.67e-05 | 9 | 26 | 2 | IPR004837 | |
| Domain | VDCCAlpha1 | 8.33e-05 | 10 | 26 | 2 | IPR002077 | |
| Domain | Ion_trans_dom | 5.20e-04 | 114 | 26 | 3 | IPR005821 | |
| Domain | Ion_trans | 5.20e-04 | 114 | 26 | 3 | PF00520 | |
| Domain | I-set | 2.85e-02 | 190 | 26 | 2 | PF07679 | |
| Domain | Ig_I-set | 2.85e-02 | 190 | 26 | 2 | IPR013098 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | 1.40e-08 | 417 | 24 | 9 | M4072 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC6A9 SLC8A2 SLC8A1 ATP11A NIPAL3 SLC1A2 SLC1A3 SLC1A6 SLC5A6 TPCN1 | 6.87e-08 | 681 | 24 | 10 | MM14985 |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 9.70e-08 | 238 | 24 | 7 | MM15076 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 1.32e-07 | 249 | 24 | 7 | M5988 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC6A9 SLC8A2 SLC8A1 ATP11A NIPAL3 SLC1A2 SLC1A3 SLC1A6 SLC5A6 TPCN1 | 1.42e-07 | 736 | 24 | 10 | M27287 |
| Pathway | KEGG_OLFACTORY_TRANSDUCTION | 1.56e-07 | 389 | 24 | 8 | M14091 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | 5.20e-07 | 636 | 24 | 9 | M41834 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 9.10e-07 | 108 | 24 | 5 | M823 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 9.53e-07 | 109 | 24 | 5 | MM15074 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 1.13e-06 | 211 | 24 | 6 | MM14502 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 4.70e-06 | 270 | 24 | 6 | M15514 | |
| Pathway | REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE | 8.57e-06 | 24 | 24 | 3 | M630 | |
| Pathway | REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE | 8.57e-06 | 24 | 24 | 3 | MM14834 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 1.61e-05 | 335 | 24 | 6 | MM14503 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 5.10e-05 | 411 | 24 | 6 | M735 | |
| Pathway | WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING | 8.48e-05 | 140 | 24 | 4 | M42572 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE | 8.56e-05 | 51 | 24 | 3 | MM14499 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE | 8.56e-05 | 51 | 24 | 3 | M4281 | |
| Pathway | REACTOME_SODIUM_CALCIUM_EXCHANGERS | 1.51e-04 | 11 | 24 | 2 | M27336 | |
| Pathway | REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING | 1.51e-04 | 11 | 24 | 2 | M26913 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 1.51e-04 | 11 | 24 | 2 | M47958 | |
| Pathway | REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING | 1.51e-04 | 11 | 24 | 2 | MM14498 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 1.81e-04 | 12 | 24 | 2 | M27326 | |
| Pathway | REACTOME_SODIUM_CALCIUM_EXCHANGERS | 2.14e-04 | 13 | 24 | 2 | MM15078 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 2.14e-04 | 178 | 24 | 4 | M2890 | |
| Pathway | WP_DRAVET_SYNDROME_SCN1AA1783V_POINT_MUTATION_MODEL | 2.49e-04 | 73 | 24 | 3 | MM16641 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 2.50e-04 | 14 | 24 | 2 | MM15052 | |
| Pathway | KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY | 6.88e-04 | 23 | 24 | 2 | M47666 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL | 8.14e-04 | 25 | 24 | 2 | M47948 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 9.50e-04 | 27 | 24 | 2 | MM15053 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 1.02e-03 | 28 | 24 | 2 | M924 | |
| Pathway | WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION | 1.41e-03 | 132 | 24 | 3 | M48110 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 1.91e-03 | 147 | 24 | 3 | MM15854 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 2.07e-03 | 151 | 24 | 3 | M39329 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 2.66e-03 | 165 | 24 | 3 | MM15026 | |
| Pathway | KEGG_TYPE_II_DIABETES_MELLITUS | 2.87e-03 | 47 | 24 | 2 | M19708 | |
| Pathway | WP_SYNAPTIC_VESICLE_PATHWAY | 3.37e-03 | 51 | 24 | 2 | M39457 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 3.77e-03 | 54 | 24 | 2 | M27460 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 3.77e-03 | 54 | 24 | 2 | MM15202 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 4.76e-03 | 203 | 24 | 3 | M5485 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 4.78e-03 | 61 | 24 | 2 | MM15071 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | 6.25e-03 | 70 | 24 | 2 | MM14984 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 6.60e-03 | 72 | 24 | 2 | MM14631 | |
| Pathway | REACTOME_PLATELET_HOMEOSTASIS | 7.33e-03 | 76 | 24 | 2 | MM15051 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 7.71e-03 | 78 | 24 | 2 | M1921 | |
| Pathway | KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM | 8.69e-03 | 83 | 24 | 2 | M8728 | |
| Pathway | REACTOME_PLATELET_HOMEOSTASIS | 9.31e-03 | 86 | 24 | 2 | M916 | |
| Pathway | KEGG_DILATED_CARDIOMYOPATHY | 1.02e-02 | 90 | 24 | 2 | M835 | |
| Pathway | WP_OXIDATIVE_STRESS_AND_REDOX_PATHWAY | 1.06e-02 | 92 | 24 | 2 | MM15823 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 1.31e-02 | 103 | 24 | 2 | MM15196 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 1.44e-02 | 108 | 24 | 2 | M17034 | |
| Pubmed | 1.82e-10 | 541 | 27 | 9 | 14983052 | ||
| Pubmed | Inositol 1,4,5-trisphosphate signaling maintains the activity of glutamate uptake in Bergmann glia. | 4.17e-10 | 3 | 27 | 3 | 20958799 | |
| Pubmed | Impact of Reduced Cerebellar EAAT Expression on Purkinje Cell Firing Pattern of NPC1-deficient Mice. | 1.67e-09 | 4 | 27 | 3 | 29463856 | |
| Pubmed | Cerebellar granule cell signaling is indispensable for normal motor performance. | 1.67e-09 | 4 | 27 | 3 | 37141091 | |
| Pubmed | 1.67e-09 | 4 | 27 | 3 | 9379843 | ||
| Pubmed | 4.17e-09 | 5 | 27 | 3 | 9129177 | ||
| Pubmed | Different evolutionary processes shaped the mouse and human olfactory receptor gene families. | 6.02e-09 | 340 | 27 | 7 | 11875048 | |
| Pubmed | 6.02e-09 | 340 | 27 | 7 | 11802173 | ||
| Pubmed | 6.40e-09 | 343 | 27 | 7 | 32295537 | ||
| Pubmed | 6.79e-09 | 346 | 27 | 7 | 14611657 | ||
| Pubmed | 1.74e-08 | 105 | 27 | 5 | 30280653 | ||
| Pubmed | 2.00e-08 | 405 | 27 | 7 | 38187761 | ||
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 2.09e-08 | 38 | 27 | 4 | 30786075 | |
| Pubmed | 7.60e-08 | 52 | 27 | 4 | 26590417 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 26057049 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 29741614 | ||
| Pubmed | Glutamate transport by retinal Muller cells in glutamate/aspartate transporter-knockout mice. | 5.80e-07 | 2 | 27 | 2 | 15390100 | |
| Pubmed | Glutamate transporter mRNA expression in proliferative zones of the developing and adult murine CNS. | 5.80e-07 | 2 | 27 | 2 | 8601800 | |
| Pubmed | Contribution of a glial glutamate transporter to GABA synthesis in the retina. | 5.80e-07 | 2 | 27 | 2 | 15305132 | |
| Pubmed | Genetic knockout and pharmacologic inhibition of NCX2 cause natriuresis and hypercalciuria. | 5.80e-07 | 2 | 27 | 2 | 25498502 | |
| Pubmed | Glial glutamate transporters and maturation of the mouse somatosensory cortex. | 5.80e-07 | 2 | 27 | 2 | 12967927 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 31582286 | ||
| Pubmed | Decreased EAAT2 protein expression in the essential tremor cerebellar cortex. | 5.80e-07 | 2 | 27 | 2 | 25391854 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 23583179 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 23913256 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 16647773 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 11792462 | ||
| Pubmed | De Novo Mutations in SLC1A2 and CACNA1A Are Important Causes of Epileptic Encephalopathies. | 5.80e-07 | 2 | 27 | 2 | 27476654 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 25064059 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 12878755 | ||
| Pubmed | Functional glutamate transport in rodent optic nerve axons and glia. | 5.80e-07 | 2 | 27 | 2 | 18551624 | |
| Pubmed | Roles of Na(+)/Ca(2+) exchanger isoforms NCX1 and NCX2 in motility in mouse ileum. | 5.80e-07 | 2 | 27 | 2 | 27411318 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 17289278 | ||
| Pubmed | Na+/Ca2+ exchanger contributes to stool transport in mice with experimental diarrhea. | 5.80e-07 | 2 | 27 | 2 | 27928109 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 12546822 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 19168136 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 29051084 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 16197522 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 30851309 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 19685014 | ||
| Pubmed | Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. | 5.80e-07 | 2 | 27 | 2 | 9180080 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 23415275 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 16381801 | ||
| Pubmed | Differential roles of glial and neuronal glutamate transporters in Purkinje cell synapses. | 5.80e-07 | 2 | 27 | 2 | 16177048 | |
| Pubmed | Glutamate transporters: a key piece in the glutamate puzzle of major depressive disorder. | 5.80e-07 | 2 | 27 | 2 | 23706640 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 25036385 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 12558972 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 28655840 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 26787195 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 23356950 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 22092549 | ||
| Pubmed | Functions of the two glutamate transporters GLAST and GLT-1 in the retina. | 5.80e-07 | 2 | 27 | 2 | 9539795 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 19338517 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 29891059 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 23939750 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 32065951 | ||
| Pubmed | Roles of glial glutamate transporters in shaping EPSCs at the climbing fiber-Purkinje cell synapses. | 5.80e-07 | 2 | 27 | 2 | 16377014 | |
| Pubmed | Distinct roles for Cav2.1-2.3 in activity-dependent synaptic dynamics. | 1.74e-06 | 3 | 27 | 2 | 24523520 | |
| Pubmed | The potential role of glutamate transporters in the pathogenesis of normal tension glaucoma. | 1.74e-06 | 3 | 27 | 2 | 17607354 | |
| Pubmed | δ-Opioid receptors up-regulate excitatory amino acid transporters in mouse astrocytes. | 1.74e-06 | 3 | 27 | 2 | 25052197 | |
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 20220082 | ||
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 38996073 | ||
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 25662838 | ||
| Pubmed | Impaired glutamate transport in a mouse model of tau pathology in astrocytes. | 1.74e-06 | 3 | 27 | 2 | 16407562 | |
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 29594857 | ||
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 9600674 | ||
| Pubmed | Immunosuppressive drugs, immunophilins, and functional expression of NCX isoforms. | 1.74e-06 | 3 | 27 | 2 | 23224887 | |
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 23224890 | ||
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 23224882 | ||
| Pubmed | Increased expression and function of glutamate transporters in multiple sclerosis. | 1.74e-06 | 3 | 27 | 2 | 16061389 | |
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 32585762 | ||
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 21382638 | ||
| Pubmed | Distribution of glutamate transporters in the human placenta. | 1.74e-06 | 3 | 27 | 2 | 15135231 | |
| Pubmed | Aberrant Amygdala-Dependent Cued Fear Memory in Na+/Ca2+ Exchanger 1 Heterozygous Mice. | 1.74e-06 | 3 | 27 | 2 | 30324228 | |
| Pubmed | Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex. | 1.74e-06 | 3 | 27 | 2 | 7521911 | |
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 17317768 | ||
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 27208619 | ||
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 28173092 | ||
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 24843004 | ||
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 28821644 | ||
| Pubmed | The downregulation of NCXs is positively correlated with the prognosis of stage II-IV colon cancer. | 1.74e-06 | 3 | 27 | 2 | 34127021 | |
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 24095695 | ||
| Pubmed | Glutamate transporters regulate lesion-induced plasticity in the developing somatosensory cortex. | 1.74e-06 | 3 | 27 | 2 | 18463253 | |
| Pubmed | Sodium-calcium exchange in intracellular calcium handling of human airway smooth muscle. | 1.74e-06 | 3 | 27 | 2 | 21858195 | |
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 17727989 | ||
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 9671661 | ||
| Pubmed | Dynamic changes in expression of glutamate transporter mRNAs in developing brain. | 1.74e-06 | 3 | 27 | 2 | 8733726 | |
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 19283393 | ||
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 17221839 | ||
| Pubmed | 3.19e-06 | 300 | 27 | 5 | 19086053 | ||
| Pubmed | Expression of Glutamate Transporters in Mouse Liver, Kidney, and Intestine. | 3.48e-06 | 4 | 27 | 2 | 29303644 | |
| Pubmed | Synapse and Active Zone Assembly in the Absence of Presynaptic Ca2+ Channels and Ca2+ Entry. | 3.48e-06 | 4 | 27 | 2 | 32616470 | |
| Pubmed | Caveolin-1 Sensitivity of Excitatory Amino Acid Transporters EAAT1, EAAT2, EAAT3, and EAAT4. | 3.48e-06 | 4 | 27 | 2 | 26690923 | |
| Pubmed | 3.48e-06 | 4 | 27 | 2 | 26358886 | ||
| Pubmed | Calcineurin inhibits Na+/Ca2+ exchange in phenylephrine-treated hypertrophic cardiomyocytes. | 3.48e-06 | 4 | 27 | 2 | 15557343 | |
| Pubmed | 3.48e-06 | 4 | 27 | 2 | 22424243 | ||
| Pubmed | 3.48e-06 | 4 | 27 | 2 | 15140926 | ||
| Pubmed | 3.48e-06 | 4 | 27 | 2 | 32768484 | ||
| Pubmed | Down-Regulation of Excitatory Amino Acid Transporters EAAT1 and EAAT2 by the Kinases SPAK and OSR1. | 3.48e-06 | 4 | 27 | 2 | 26233565 | |
| Pubmed | Importance of K+-dependent Na+/Ca2+-exchanger 2, NCKX2, in motor learning and memory. | 3.48e-06 | 4 | 27 | 2 | 16407245 | |
| Interaction | SSTR3 interactions | 4.19e-08 | 393 | 19 | 7 | int:SSTR3 | |
| Cytoband | 9q31.1 | 2.69e-04 | 41 | 27 | 2 | 9q31.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q31 | 2.95e-03 | 137 | 27 | 2 | chr9q31 | |
| Cytoband | 14q11.2 | 5.03e-03 | 180 | 27 | 2 | 14q11.2 | |
| GeneFamily | Solute carriers | 2.62e-08 | 395 | 24 | 8 | 752 | |
| GeneFamily | Olfactory receptors, family 11 | 3.58e-06 | 23 | 24 | 3 | 159 | |
| GeneFamily | Olfactory receptors, family 13 | 3.58e-06 | 23 | 24 | 3 | 162 | |
| GeneFamily | Calcium voltage-gated channel subunits | 5.38e-04 | 26 | 24 | 2 | 253 | |
| GeneFamily | Olfactory receptors, family 2 | 9.77e-03 | 113 | 24 | 2 | 149 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.91e-02 | 161 | 24 | 2 | 593 | |
| Coexpression | GSE17721_PAM3CSK4_VS_CPG_2H_BMDC_DN | 3.10e-05 | 200 | 24 | 4 | M3858 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | 4.30e-05 | 1106 | 24 | 7 | M39071 | |
| CoexpressionAtlas | BM Top 100 - amygdala | 3.63e-05 | 73 | 19 | 3 | BM Top 100 - amygdala | |
| CoexpressionAtlas | BM Top 100 - hippocampus | 4.43e-05 | 78 | 19 | 3 | BM Top 100 - hippocampus | |
| CoexpressionAtlas | BM Top 100 - accumbens | 4.43e-05 | 78 | 19 | 3 | BM Top 100 - accumbens | |
| CoexpressionAtlas | JC_iEC_top-relative-expression-ranked_2500_k-means-cluster#3 | 1.47e-04 | 311 | 19 | 4 | JC_iEC_2500_K3 | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage_3|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.04e-04 | 152 | 27 | 3 | f717aae4882e9b67e5e40f4ef5b0d35f74a89165 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-04 | 154 | 27 | 3 | 5ed64bbf603290e6dc34f81d145982690b89dd0d | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-04 | 156 | 27 | 3 | d72c2f5f72d269e29033f8728d924e0d4c8772c7 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 158 | 27 | 3 | d3446fc98eff09c3626b47a2c90d07cd985378b5 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 158 | 27 | 3 | df614450e10629dc9115d7365397663e82f9e48f | |
| ToppCell | 367C-Epithelial_cells-Epithelial-A_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.30e-04 | 164 | 27 | 3 | b0ed8cb6000ce8bf94444307e4b7b3574fa3fab2 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-A_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.30e-04 | 164 | 27 | 3 | 3aea6207a011ad55a1aeb2ed9fb54d31b23694b5 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Myeloid-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-04 | 166 | 27 | 3 | 03a47b8687f54955e84df1edcb230db332c4ca8f | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.45e-04 | 170 | 27 | 3 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 1.45e-04 | 170 | 27 | 3 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Epcam____brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-04 | 171 | 27 | 3 | 8e7223ba447947cdf4e1c82a52fd90439cf3d8f6 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-04 | 171 | 27 | 3 | 007f148f4611ea1826edfa9f91ced36541ad9f5a | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-04 | 171 | 27 | 3 | 99176a932569fa1c7e1c01009684f5a65244b96e | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-04 | 172 | 27 | 3 | e15ab284df6dd241d4481f98864b18c39d757b8c | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.50e-04 | 172 | 27 | 3 | 490745024730df6357f6c2b81d7a64e21557c0d5 | |
| ToppCell | facs-Large_Intestine-Proximal-3m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-04 | 173 | 27 | 3 | 99532bb768ee35fed939a377acb5215d3f8904bd | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-04 | 173 | 27 | 3 | e1378201b15ffb98e196ac39fe3ee4b4078953bd | |
| ToppCell | 3'_v3-GI_small-bowel-Myeloid_Mac-Macrophage|GI_small-bowel / Manually curated celltypes from each tissue | 1.61e-04 | 176 | 27 | 3 | 4be270f6bb7da4070f972aca403109751646d155 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-04 | 180 | 27 | 3 | 6ac62bf1251978c8c12e715f7b73144fca619794 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.74e-04 | 181 | 27 | 3 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid-Macrophages|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.77e-04 | 182 | 27 | 3 | ea39b1b5db185b0cb11dfa2e01f3f972effbd770 | |
| ToppCell | COVID-19-Heart-CM_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.83e-04 | 184 | 27 | 3 | e737f0f14c49b07bbb04a165083ac32210bc5690 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 1.83e-04 | 184 | 27 | 3 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.86e-04 | 185 | 27 | 3 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.86e-04 | 185 | 27 | 3 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.86e-04 | 185 | 27 | 3 | 8207f9eff113eed429e961748c6b17d672a13b33 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.89e-04 | 186 | 27 | 3 | 56c139e679d640ea901ead657a8e8887e0fca098 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-04 | 186 | 27 | 3 | 7278a1a1bf9bb27aeb03852134defb31b62f30d6 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.89e-04 | 186 | 27 | 3 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.95e-04 | 188 | 27 | 3 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-04 | 189 | 27 | 3 | f57200c93d39c9bce1adba0a6a1c178c028dd86b | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.98e-04 | 189 | 27 | 3 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 2.01e-04 | 190 | 27 | 3 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 2.01e-04 | 190 | 27 | 3 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-04 | 191 | 27 | 3 | fd345837bfc40d85256b9a7e4fd3343bcbfe0ae5 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 2.04e-04 | 191 | 27 | 3 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | COVID-19-lung-Macrophage_PPARGhi_CD5Lhi|lung / Disease (COVID-19 only), tissue and cell type | 2.04e-04 | 191 | 27 | 3 | dab953682b8c9ed680a799161f837f792a7e4f33 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 2.04e-04 | 191 | 27 | 3 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | COVID-19-lung-Macrophage_PPARGhi_CD5Lhi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.08e-04 | 192 | 27 | 3 | bcfb9c005166bc0b4f8ee2dfc0c1540e8bf0e1ff | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-04 | 192 | 27 | 3 | d2161842a38146261847fc9061ba9322e0f087e0 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 2.08e-04 | 192 | 27 | 3 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)-D175|Adult / Lineage, Cell type, age group and donor | 2.08e-04 | 192 | 27 | 3 | 733491e932350e3c216a626cc49c3cd3fe970a82 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-04 | 193 | 27 | 3 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)|Adult / Lineage, Cell type, age group and donor | 2.11e-04 | 193 | 27 | 3 | 31c0978ba78c9516d498aec0798902e57555e557 | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)-D122|Adult / Lineage, Cell type, age group and donor | 2.11e-04 | 193 | 27 | 3 | cc1b6d3bf56e4a88f6fe23dd036a83cf5538c958 | |
| ToppCell | COPD-Myeloid|COPD / Disease state, Lineage and Cell class | 2.11e-04 | 193 | 27 | 3 | f58552e286aa27e592497ad78776f58f8ee09841 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-04 | 193 | 27 | 3 | 0c652ebe22ce5d2927599dd97ef1920547858395 | |
| ToppCell | NS-critical-d_07-13-Myeloid-Monocyte-derived_Macrophage|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.11e-04 | 193 | 27 | 3 | 0dd83b21e164147abfd511a927615c40a28781a2 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-04 | 193 | 27 | 3 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 2.11e-04 | 193 | 27 | 3 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-04 | 193 | 27 | 3 | 5fb7808dd971c1cc64c2bd4f8f1de646fb2d77f4 | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 2.17e-04 | 195 | 27 | 3 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | COVID-19-lung-Macrophage_CD163hi_MERTKhi|lung / Disease (COVID-19 only), tissue and cell type | 2.17e-04 | 195 | 27 | 3 | 148fff8c3c9ba45ec36e98dff1be57e3f8294506 | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)|Adult / Lineage, Cell type, age group and donor | 2.17e-04 | 195 | 27 | 3 | 55e25f702af19146a161861cfd15f40bbda1dc35 | |
| ToppCell | Children_(3_yrs)-Immune-monocyte-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.17e-04 | 195 | 27 | 3 | 81a28289eda1a8a1a31b7357106f64ac5000e172 | |
| ToppCell | NS-critical-d_07-13-Myeloid-Non-resident_Macrophage|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.17e-04 | 195 | 27 | 3 | ee8743d39996bb756f50db32748e8a902d3294b8 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 2.17e-04 | 195 | 27 | 3 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | COVID-19-lung-Macrophage_CD163hi_MERTKhi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.20e-04 | 196 | 27 | 3 | 7026c1fc33425e5476063d17c79e4b79356a9e01 | |
| ToppCell | 3'_v3-Lung|World / Manually curated celltypes from each tissue | 2.20e-04 | 196 | 27 | 3 | a04f8384b734ce67ec402e64bd891a6274f04744 | |
| ToppCell | COVID-19-lung-Macrophage_metabolically_active|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.20e-04 | 196 | 27 | 3 | 1b7928f4eee94d4bb6ea410bab68a471dba12979 | |
| ToppCell | COVID-19-lung-Macrophage_metabolically_active|lung / Disease (COVID-19 only), tissue and cell type | 2.20e-04 | 196 | 27 | 3 | a753d76d764c181eecb0e17a794a2e7d0ff70136 | |
| ToppCell | NS-critical-LOC-Myeloid-Macrophage|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.24e-04 | 197 | 27 | 3 | 5fb0696376a5501b7c87e0f2f5e4fff3da2903f2 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macro_interstitial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.24e-04 | 197 | 27 | 3 | 780ab4a9f1dbf1f58b70a716ba2949c4f51b9295 | |
| ToppCell | COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi|lung / Disease (COVID-19 only), tissue and cell type | 2.24e-04 | 197 | 27 | 3 | 3896729740d151f0eb845f1961c7b969bfbdd28d | |
| ToppCell | Adult-Immune|Adult / Lineage, Cell type, age group and donor | 2.27e-04 | 198 | 27 | 3 | 9bfd7b88aa646eaf5eddb15cf985c7ca910cb35e | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.27e-04 | 198 | 27 | 3 | e125eb8aa57c172e5518874da1bd25998292f5e2 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-04 | 198 | 27 | 3 | 43a2ce64fa309bac89a44ea320e87ae2cc39f782 | |
| ToppCell | COVID-19-Myeloid|COVID-19 / group, cell type (main and fine annotations) | 2.27e-04 | 198 | 27 | 3 | 33f0a919188a67d2a876b52c61a1cec2c9747969 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Macroglial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-04 | 198 | 27 | 3 | 731a90f7e68b19e387499d63e3979af78b503b0c | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_other-Macro_interstitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.27e-04 | 198 | 27 | 3 | 9a77038e5db0ea757fd7ebcab294785b166ddc12 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.27e-04 | 198 | 27 | 3 | 0baeb8e2c199ff10bb5c829c523546af3c9227c1 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_other-Macro_CHIT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.27e-04 | 198 | 27 | 3 | 0b41b3d6c2db795320e8b65d40d85fb8b618cc34 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_macrophage-macrophage|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.27e-04 | 198 | 27 | 3 | 5aaf3861c53763cf09bb628c9d2eabb6a7277021 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_macrophage|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.27e-04 | 198 | 27 | 3 | 9aaff68107ae4542f904b142d23669f2fcd557ac | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alv_MT|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.31e-04 | 199 | 27 | 3 | 951c2ea5af4756832c2adcec3ee70a7e36331a4e | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.31e-04 | 199 | 27 | 3 | 7648860058eec66019b574ad840d6f5cfa4476d9 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.31e-04 | 199 | 27 | 3 | 7ee2805fd9143eba11bf6832267b62189683608b | |
| ToppCell | COVID-19-Myeloid-Alveolar_macrophages|COVID-19 / group, cell type (main and fine annotations) | 2.31e-04 | 199 | 27 | 3 | e1c85ca85fa22c4a4fa1bbdf55304bf3628485ee | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_interstitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.31e-04 | 199 | 27 | 3 | 841338719d042247966867ac608146395eb8c4d9 | |
| ToppCell | critical-Myeloid-Non-resident_Macrophage|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.31e-04 | 199 | 27 | 3 | 193325768b17d3123ae855317f381a01088b5dac | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_CHIT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.31e-04 | 199 | 27 | 3 | 6ce7612ee2ae211eb0f73391e96089ad5431c537 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Macrophage_alveolar|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.31e-04 | 199 | 27 | 3 | 91c72e06a7416671977430211c57938e39e8195e | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.31e-04 | 199 | 27 | 3 | a900ef002e1ae583b70be0253d8c44dae6754916 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Macroglial|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 2.34e-04 | 200 | 27 | 3 | 70c2e577efb6b6fe8f9d970d7ecc470788efb85b | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-Macroglial-Astrocyte|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 2.34e-04 | 200 | 27 | 3 | 29f82e2ad2f1888b6b236a4392b88a84351b8ddc | |
| ToppCell | Sigmoid-Macrophage-Macrophage|Sigmoid / Region, Cell class and subclass | 2.34e-04 | 200 | 27 | 3 | 9ee3a799de7bade1bfe94b6827461633f02bc1dc | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.34e-04 | 200 | 27 | 3 | ed785a6d08ca2b350dc3307b587eadfb2886d1f9 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Macroglial-Astrocyte|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 2.34e-04 | 200 | 27 | 3 | 158ba898312c73bcb54c675a4860874a1dd58662 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.34e-04 | 200 | 27 | 3 | 2f5b71e55c2de0e77fdae6667eb57f333acc6cd1 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.34e-04 | 200 | 27 | 3 | a443e475e7a10c26a6173d1af961de6219e0e567 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Macroglial|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 2.34e-04 | 200 | 27 | 3 | 46f99bed98da09e6d3f45d4443cbaa6b6c1589bb | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-Macroglial|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 2.34e-04 | 200 | 27 | 3 | 1598a9e8efa72fda7d12df07e7716b326cdf1d5e | |
| ToppCell | Sigmoid-(6)_Macrophage-(60)_Macrophage|Sigmoid / shred on region, Cell_type, and subtype | 2.34e-04 | 200 | 27 | 3 | ad84a83a5a1893f7b053d39eddeca851463a8ff0 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-C1ql2-Excitatory_Neuron.Slc17a7.C1ql2-Penk_(Dentate_Principal_cells)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 6.41e-04 | 62 | 27 | 2 | 385e7de8b6d81052ee7dfc0958c7b3d924f73130 | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.17e-04 | 70 | 27 | 2 | 5720505ef03d65c73028616c808420e282823bde | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma-7|TCGA-Kidney / Sample_Type by Project: Shred V9 | 1.56e-03 | 97 | 27 | 2 | 88ac93868312c9b57a1b23edc76b5907847d2c1d | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Papillary_Squamous_Cell_Carcinoma|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.75e-03 | 103 | 27 | 2 | 9a3e79ccb2d1084d83e35c13f57f31cbabbe912d | |
| ToppCell | RV-03._Atrial_Cardiomyocyte|RV / Chamber and Cluster_Paper | 1.82e-03 | 105 | 27 | 2 | 49e16b11f16e83a7d17d162c14bce991201bcc2a | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-Like-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.93e-03 | 108 | 27 | 2 | d620f07243c2628494e689bbfabc14c453f4b1f4 | |
| ToppCell | Globus_pallidus-Macroglia-ASTROCYTE-Gja1|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.03e-03 | 111 | 27 | 2 | 7d7aad8e9811c67fb9abfb4ebc75def01a517adf | |
| Computational | Genes in the cancer module 186. | 1.79e-04 | 20 | 11 | 2 | MODULE_186 | |
| Drug | cyclothiazide | 1.22e-09 | 103 | 25 | 6 | CID000002910 | |
| Drug | DCG-IV | 1.04e-08 | 68 | 25 | 5 | CID000115114 | |
| Drug | sodium | SLC6A9 SLC8A2 SLC8A1 ATP11A SLC1A2 SLC1A3 SLC1A6 SLC5A6 TPCN1 GABRA6 | 2.65e-08 | 944 | 25 | 10 | CID000000923 |
| Drug | enzacamene | 2.62e-07 | 129 | 25 | 5 | ctd:C038939 | |
| Drug | anthglutin | 3.32e-07 | 13 | 25 | 3 | CID000125748 | |
| Drug | octylmethoxycinnamate | 3.80e-07 | 139 | 25 | 5 | ctd:C118580 | |
| Drug | gamma-aminobutyric acid | 5.63e-07 | 474 | 25 | 7 | CID000000119 | |
| Drug | potassium | CACNA1A CACNA1E SLC8A2 SLC8A1 SLC1A2 SLC1A3 SLC1A6 TPCN1 GABRA6 | 6.78e-07 | 1008 | 25 | 9 | CID000000813 |
| Drug | butylparaben | 6.95e-07 | 157 | 25 | 5 | ctd:C038091 | |
| Drug | riluzole | 1.16e-06 | 174 | 25 | 5 | CID000005070 | |
| Drug | AC1L9FMM | 1.17e-06 | 73 | 25 | 4 | CID000444055 | |
| Drug | N-methyl-DL-aspartic acid | 4.83e-06 | 655 | 25 | 7 | CID000004376 | |
| Drug | 3-aminopropylphosphinic acid | 5.68e-06 | 32 | 25 | 3 | CID006335948 | |
| Drug | AC 110 | 6.94e-06 | 4 | 25 | 2 | CID000022860 | |
| Drug | YVN | 6.94e-06 | 4 | 25 | 2 | CID009547990 | |
| Drug | ethyldichloroarsine | 7.48e-06 | 35 | 25 | 3 | CID000011711 | |
| Drug | sipatrigine | 8.87e-06 | 37 | 25 | 3 | CID000060803 | |
| Drug | bepridil | 1.03e-05 | 126 | 25 | 4 | CID000002351 | |
| Drug | amoxapine | 1.72e-05 | 46 | 25 | 3 | CID000002170 | |
| Drug | 3,4-dihydroquinazoline | 1.73e-05 | 6 | 25 | 2 | CID000583065 | |
| Drug | alpha-sialylcholesterol | 1.73e-05 | 6 | 25 | 2 | CID000133976 | |
| Drug | nimodipine | 1.80e-05 | 145 | 25 | 4 | CID000004497 | |
| Drug | beta-hydroxyaspartic acid | 1.84e-05 | 47 | 25 | 3 | CID000005425 | |
| Drug | procaine | 2.22e-05 | 153 | 25 | 4 | CID000004914 | |
| Drug | APMPA | 2.42e-05 | 7 | 25 | 2 | CID000512300 | |
| Drug | Cinildipine | 3.12e-05 | 56 | 25 | 3 | CID000002752 | |
| Drug | 2,3-PDCA | 3.23e-05 | 8 | 25 | 2 | CID000127037 | |
| Drug | 1-hydroxyimidazole | 3.23e-05 | 8 | 25 | 2 | CID003614351 | |
| Drug | 1-hydroxypyrazole | 3.23e-05 | 8 | 25 | 2 | CID003016733 | |
| Drug | gabapentin | 3.28e-05 | 169 | 25 | 4 | CID000003446 | |
| Drug | nilvadipine | 3.84e-05 | 60 | 25 | 3 | CID000004494 | |
| Drug | ONO-2506 | 4.15e-05 | 9 | 25 | 2 | CID000208925 | |
| Drug | diethylmercury | 4.15e-05 | 9 | 25 | 2 | CID000012318 | |
| Drug | lercanidipine | 4.45e-05 | 63 | 25 | 3 | CID000065866 | |
| Drug | NO-711 | 5.11e-05 | 66 | 25 | 3 | CID000004515 | |
| Drug | valproate | 5.15e-05 | 381 | 25 | 5 | CID000003121 | |
| Drug | gallopamil | 5.35e-05 | 67 | 25 | 3 | CID000001234 | |
| Drug | dihydropyridine | 5.51e-05 | 193 | 25 | 4 | CID000104822 | |
| Drug | L-Glutamic Acid | 5.59e-05 | 68 | 25 | 3 | DB00142 | |
| Drug | glutamate | 5.79e-05 | 962 | 25 | 7 | CID000000611 | |
| Drug | AC1L2AC7 | 5.84e-05 | 69 | 25 | 3 | CID000068733 | |
| Drug | Lactobionic acid [96-82-2]; Up 200; 11.2uM; PC3; HT_HG-U133A | 5.96e-05 | 197 | 25 | 4 | 6605_UP | |
| Drug | Spironolactone [52-01-7]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 5.96e-05 | 197 | 25 | 4 | 6255_UP | |
| Drug | haloperidol | 6.04e-05 | 394 | 25 | 5 | CID000003559 | |
| Drug | Tyloxapol [25301-02-4]; Up 200; 4uM; PC3; HT_HG-U133A | 6.08e-05 | 198 | 25 | 4 | 4611_UP | |
| Drug | 9-3a | 6.33e-05 | 11 | 25 | 2 | CID011963492 | |
| Drug | leys | 6.33e-05 | 11 | 25 | 2 | CID000484683 | |
| Drug | Barium | 6.63e-05 | 72 | 25 | 3 | ctd:D001464 | |
| Drug | DL-Serine | 6.70e-05 | 203 | 25 | 4 | CID000000617 | |
| Drug | CAS 298-57-7 | 6.91e-05 | 73 | 25 | 3 | CID000002761 | |
| Drug | ethosuximide | 7.20e-05 | 74 | 25 | 3 | CID000003291 | |
| Drug | AC1L1E5T | 7.20e-05 | 74 | 25 | 3 | CID000002653 | |
| Drug | bumetanide | 7.50e-05 | 209 | 25 | 4 | CID000002471 | |
| Drug | AC1L2VU3 | 7.59e-05 | 12 | 25 | 2 | CID000129572 | |
| Drug | hilE | 7.80e-05 | 76 | 25 | 3 | CID000000791 | |
| Drug | nisoldipine | 8.43e-05 | 78 | 25 | 3 | CID000004499 | |
| Drug | 4-aminospiroperidol | 8.96e-05 | 13 | 25 | 2 | CID000195080 | |
| Drug | dopamine | 9.98e-05 | 715 | 25 | 6 | CID000000681 | |
| Drug | Sodium | 1.05e-04 | 84 | 25 | 3 | ctd:D012964 | |
| Drug | AC1L1BXF | 1.09e-04 | 85 | 25 | 3 | CID000001650 | |
| Drug | taurine | 1.10e-04 | 231 | 25 | 4 | CID000001123 | |
| Drug | 3-(1H-pyrrole-2-carboxylate | 1.14e-04 | 233 | 25 | 4 | CID000005114 | |
| Drug | Ro106-9920 | 1.20e-04 | 15 | 25 | 2 | CID003906779 | |
| Drug | butamben | 1.20e-04 | 15 | 25 | 2 | CID000002482 | |
| Drug | AC1L9B1Q | 1.20e-04 | 15 | 25 | 2 | CID000416151 | |
| Drug | compound 8b | 1.20e-04 | 15 | 25 | 2 | CID000447695 | |
| Drug | hexachlorophene | 1.29e-04 | 90 | 25 | 3 | CID000003598 | |
| Drug | NBQX | 1.29e-04 | 90 | 25 | 3 | CID003272523 | |
| Drug | Granosan M | 1.38e-04 | 16 | 25 | 2 | CID000005442 | |
| Drug | pentasulfane | 1.38e-04 | 16 | 25 | 2 | CID000448216 | |
| Drug | manidipine | 1.51e-04 | 95 | 25 | 3 | CID000004008 | |
| Drug | Ethylene Chlorohydrin | 1.56e-04 | 17 | 25 | 2 | ctd:D005023 | |
| Drug | Dalce | 1.56e-04 | 17 | 25 | 2 | CID005486712 | |
| Drug | homovanillic acid | 1.61e-04 | 97 | 25 | 3 | CID000001738 | |
| Drug | nitrendipine | 1.66e-04 | 98 | 25 | 3 | CID000004507 | |
| Drug | manganese sulfate | 1.75e-04 | 18 | 25 | 2 | ctd:C039798 | |
| Drug | isradipine | 1.76e-04 | 100 | 25 | 3 | CID000003784 | |
| Drug | methanethiosulfonate | 1.92e-04 | 103 | 25 | 3 | CID004188587 | |
| Drug | N6-Me-dAdo | 1.96e-04 | 19 | 25 | 2 | CID000168948 | |
| Drug | pranidipine | 1.96e-04 | 19 | 25 | 2 | CID006436048 | |
| Drug | alanine | 1.98e-04 | 269 | 25 | 4 | CID000000602 | |
| Drug | DL-valine | 2.04e-04 | 105 | 25 | 3 | CID000001182 | |
| Drug | loperamide | 2.04e-04 | 105 | 25 | 3 | CID000003954 | |
| Drug | N-ethylglutamine | 2.17e-04 | 20 | 25 | 2 | CID000228398 | |
| Drug | clopyralid | 2.17e-04 | 20 | 25 | 2 | CID000015553 | |
| Drug | Riluzole | 2.17e-04 | 20 | 25 | 2 | ctd:D019782 | |
| Drug | AC1L1KC5 | 2.66e-04 | 541 | 25 | 5 | CID000005428 | |
| Drug | lamotrigine | 2.73e-04 | 116 | 25 | 3 | CID000003878 | |
| Drug | LY320135 | 2.89e-04 | 23 | 25 | 2 | CID005311257 | |
| Drug | alpha-conotoxin SI | 2.89e-04 | 23 | 25 | 2 | CID000163979 | |
| Drug | manganese sulfate monohydrate | 2.89e-04 | 23 | 25 | 2 | CID000166832 | |
| Drug | allo-threonine | 2.94e-04 | 119 | 25 | 3 | CID000000205 | |
| Drug | CNQX | 3.48e-04 | 126 | 25 | 3 | CID000002821 | |
| Drug | pimozide | 3.56e-04 | 127 | 25 | 3 | CID000016362 | |
| Drug | halothane | 3.57e-04 | 314 | 25 | 4 | CID000003562 | |
| Drug | Linuron | 3.65e-04 | 128 | 25 | 3 | ctd:D008044 | |
| Drug | mAHP | 4.00e-04 | 27 | 25 | 2 | CID000220531 | |
| Drug | p-MB | 4.00e-04 | 27 | 25 | 2 | CID000007627 | |
| Drug | eniluracil | 4.00e-04 | 27 | 25 | 2 | CID000043157 | |
| Drug | bisindolylmaleimide II | 4.30e-04 | 28 | 25 | 2 | CID000002397 | |
| Disease | familial hemiplegic migraine 1 (implicated_via_orthology) | 1.59e-06 | 3 | 22 | 2 | DOID:0111181 (implicated_via_orthology) | |
| Disease | Alternating hemiplegia of childhood | 3.18e-06 | 4 | 22 | 2 | C0338488 | |
| Disease | migraine (implicated_via_orthology) | 3.18e-06 | 4 | 22 | 2 | DOID:6364 (implicated_via_orthology) | |
| Disease | Hereditary episodic ataxia | 3.18e-06 | 4 | 22 | 2 | cv:C1720189 | |
| Disease | epilepsy (implicated_via_orthology) | 6.07e-06 | 163 | 22 | 4 | DOID:1826 (implicated_via_orthology) | |
| Disease | episodic ataxia type 6 (implicated_via_orthology) | 7.95e-06 | 6 | 22 | 2 | DOID:0050994 (implicated_via_orthology) | |
| Disease | hereditary ataxia (implicated_via_orthology) | 1.11e-05 | 7 | 22 | 2 | DOID:0050951 (implicated_via_orthology) | |
| Disease | Epilepsy | 7.17e-05 | 109 | 22 | 3 | C0014544 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 1.67e-04 | 145 | 22 | 3 | DOID:1289 (implicated_via_orthology) | |
| Disease | inflammatory biomarker measurement | 1.71e-04 | 26 | 22 | 2 | EFO_0004872 | |
| Disease | Epileptic encephalopathy | 2.28e-04 | 30 | 22 | 2 | C0543888 | |
| Disease | Bipolar Disorder | 3.92e-04 | 477 | 22 | 4 | C0005586 | |
| Disease | Schizophrenia | 4.09e-04 | 883 | 22 | 5 | C0036341 | |
| Disease | Seizures | 5.52e-04 | 218 | 22 | 3 | C0036572 | |
| Disease | cognitive inhibition measurement | 6.36e-04 | 50 | 22 | 2 | EFO_0007969 | |
| Disease | Epilepsy, Cryptogenic | 1.70e-03 | 82 | 22 | 2 | C0086237 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YVFTGVFTFEMVIKM | 1281 | O00555 | |
| YVFTGVFTFEMVIKM | 1191 | Q15878 | |
| TVVVVFYGSLLFMYM | 246 | Q8NH50 | |
| VVVSLFYGTVMVMYV | 256 | Q8NGC9 | |
| RVIFTSGDMGVYYMV | 141 | O75121 | |
| VYYMVVCLVAFTIVM | 151 | O75121 | |
| IFYVMFVCMVATAVY | 241 | Q6P499 | |
| TVVSMFYGTIIYMYL | 246 | Q9Y3N9 | |
| GYFMIQIYTPCIMTV | 241 | Q16445 | |
| AVVTLYYGTMISMYV | 246 | Q8NGX0 | |
| VVTIFYGSAISMYMK | 246 | Q8NG92 | |
| TVVIIFYGTILFMYM | 246 | Q8NGS9 | |
| MVVILFYGSAIITYM | 246 | Q9H210 | |
| MVYYMSTTIIAAVLG | 121 | P43004 | |
| MRAVVYYMTTTIIAV | 121 | P43003 | |
| AAVYYMVTTIIAVFI | 131 | P48664 | |
| VYIMTLVGMVVYTFT | 381 | Q9UPI3 | |
| VVVSLFYGAIMLMYV | 246 | Q8NGC8 | |
| TVVIIFYGTILFMYM | 246 | Q8NGT0 | |
| TVTFIFQMVIYMGVV | 146 | Q9Y289 | |
| FQMVIYMGVVLYAPS | 151 | Q9Y289 | |
| MYRLTVDGVETYMVV | 186 | P78356 | |
| FNYIIPVSMYVTVEM | 356 | P98196 | |
| MMAIVYTEVAIVVKY | 1966 | Q9H5I5 | |
| VGYGMMVVSTYIGIY | 181 | P48067 | |
| LYFMTFYIVTMVVMT | 666 | Q9ULQ1 | |
| FYIVTMVVMTIIVAF | 671 | Q9ULQ1 | |
| YFVAMVYMFLGVSII | 81 | P32418 | |
| RAVVYFVAMVYMFLG | 71 | Q9UPR5 | |
| MIEGVVYEMRVYAVN | 836 | Q14896 |